Dr. Goldman is an Operating Partner on the Healthcare team focusing on investments in the pharma services sector, having joined WCAS in 2017. Dr. Goldman currently serves as the CEO of Abzena, a WCAS XII portfolio company. He was previously the Chief Executive Officer of Aptuit, a former WCAS portfolio company. Dr. Goldman brings 28 years of experience in healthcare, having held senior executive positions at ICON Plc and Point Biomedical. He currently maintains a Faculty appointment as an Associate Clinical Professor of Medicine in the division of Cardiology at the University of California, San Francisco.
Education
University of London – B.S., M.B.B.S & M.D.
Columbia University & University of California at Berkeley – Executive M.B.A.
Board Representation
Current
Abzena
Community Involvement & Additional Information
Dr. Goldman serves on the Cardiovascular Research Advisory Board, Oregon Health Sciences University and the Healthcare Pharmaceutical Management advisory board at Columbia University Business School.
Featured Investments
